135 related articles for article (PubMed ID: 2371834)
1. Histological changes in cardiac hemochromatosis improved by an iron-chelating agent. A biopsy case.
Tashiro A; Satodate R; Segawa I
Acta Pathol Jpn; 1990 Apr; 40(4):288-92. PubMed ID: 2371834
[TBL] [Abstract][Full Text] [Related]
2. Ultrastructural pathology of the heart in patients with beta-thalassaemia major.
Kyriacou K; Michaelides Y; Senkus R; Simamonian K; Pavlides N; Antoniades L; Zambartas C
Ultrastruct Pathol; 2000; 24(2):75-81. PubMed ID: 10808552
[TBL] [Abstract][Full Text] [Related]
3. The nature of storage iron in idiopathic hemochromatosis and in hemosiderosis. Electron optical, chemical, and serologic studies on isolated hemosiderin granules.
RICHTER GW
J Exp Med; 1960 Oct; 112(4):551-70. PubMed ID: 13741389
[TBL] [Abstract][Full Text] [Related]
4. Idiopathic hemochromatosis. II. Diagnosis and treatment.
Can Med Assoc J; 1967 Jun; 96(25):1642-3. PubMed ID: 6027628
[No Abstract] [Full Text] [Related]
5. An Iron-chelating Agent Improved the Cardiac Function in a Patient with Severe Heart Failure Due to Hereditary Hemochromatosis.
Setoguchi A; Kawano H; Okano S; Honda T; Kato T; Dateki S; Senoo A; Nakashima Y; Motokawa T; Ueno Y; Akashi R; Yonekura T; Sueyoshi E; Ikeda S; Miyazaki Y; Maemura K
Intern Med; 2024 Jan; 63(2):253-258. PubMed ID: 37197964
[TBL] [Abstract][Full Text] [Related]
6. Hemosiderin deposition in muscle. Report of three cases.
Vallat JM; Loubet R; Leboutet MJ; Loubet A
Acta Neuropathol; 1978 May; 42(2):153-6. PubMed ID: 654887
[TBL] [Abstract][Full Text] [Related]
7. Myocyte damage and loss of myofibers is the potential mechanism of iron overload toxicity in congestive cardiac failure in thalassemia. Complete reversal of the cardiomyopathy and normalization of iron load by deferiprone.
Kolnagou A; Michaelides Y; Kontos C; Kyriacou K; Kontoghiorghes GJ
Hemoglobin; 2008; 32(1-2):17-28. PubMed ID: 18274979
[TBL] [Abstract][Full Text] [Related]
8. Myocardial involvement in idiopathic hemochromatosis. Morphologic and clinical improvement following venesection.
Short EM; Winkle RA; Billingham ME
Am J Med; 1981 Jun; 70(6):1275-9. PubMed ID: 7234894
[TBL] [Abstract][Full Text] [Related]
9. [Cardiac hemochromatosis diagnosed by endomyocardial biopsy: the first case reported in Japan].
Baba Y; Konishi H; Yokoi Y; Sato J; Yamane W; Wakabayashi H; Yamamoto K; Kawaratani H; Yutani C
Nihon Naika Gakkai Zasshi; 1987 Oct; 76(10):1547-53. PubMed ID: 3437185
[No Abstract] [Full Text] [Related]
10. Reversal of end-stage heart failure in juvenile hemochromatosis with iron chelation therapy: a case report.
Cooray SD; Heerasing NM; Selkrig LA; Subramaniam VN; Hamblin PS; McDonald CJ; McLean CA; McNamara E; Leet AS; Roberts SK
J Med Case Rep; 2018 Jan; 12(1):18. PubMed ID: 29373985
[TBL] [Abstract][Full Text] [Related]
11. Progressive hemochromatotic cardiomyopathy despite reversal of iron deposition after liver transplantation.
Westra WH; Hruban RH; Baughman KL; Olson JL; Porterfield JK; Mitchell MC; Hutchins GM
Am J Clin Pathol; 1993 Jan; 99(1):39-44. PubMed ID: 8422014
[TBL] [Abstract][Full Text] [Related]
12. [An older female patient with refractory anemia and hemochromatosis].
Sutor GC; Ceconi C; Flemming P; Wysk J; Fabel H; Schuppert F
Dtsch Med Wochenschr; 2002 Aug; 127(34-35):1754-8. PubMed ID: 12192634
[TBL] [Abstract][Full Text] [Related]
13. Methods for noninvasive measurement of tissue iron in Cooley's anemia.
Sheth S; Tang H; Jensen JH; Altmann K; Prakash A; Printz BF; Hordof AJ; Tosti CL; Azabagic A; Swaminathan S; Brown TR; Olivieri NF; Brittenham GM
Ann N Y Acad Sci; 2005; 1054():358-72. PubMed ID: 16339684
[TBL] [Abstract][Full Text] [Related]
14. Severe Myocardial Dysfunction Reversed by Iron-Chelation Therapy in an Asian Patient with Hereditary Hemochromatosis.
Kang Y; Chen XJ; Yu CP; You GY; Zhang Q
Am J Med Sci; 2016 May; 351(5):546-8. PubMed ID: 27140717
[No Abstract] [Full Text] [Related]
15. Endomyocardial biopsy in hemochromatosis: clinicopathologic correlates in six cases.
Olson LJ; Edwards WD; Holmes DR; Miller FA; Nordstrom LA; Baldus WP
J Am Coll Cardiol; 1989 Jan; 13(1):116-20. PubMed ID: 2909558
[TBL] [Abstract][Full Text] [Related]
16. Postshunt hemochromatosis with cardiomyopathy.
Lombard CM; Strauchen JA
Hum Pathol; 1981 Dec; 12(12):1149-51. PubMed ID: 7333578
[TBL] [Abstract][Full Text] [Related]
17. Type 3 hemochromatosis and beta-thalassemia trait.
Riva A; Mariani R; Bovo G; Pelucchi S; Arosio C; Salvioni A; Vergani A; Piperno A
Eur J Haematol; 2004 May; 72(5):370-4. PubMed ID: 15059075
[TBL] [Abstract][Full Text] [Related]
18. [-Cardiomyopathy as the cause of death in genetic hemochromatosis-].
von Herbay A; Niederau C; Pilichowska M; Reinecke P; Perings C; Vester E; Strohmeyer G; Häussinger D
Z Gastroenterol; 1996 Mar; 34(3):178-82. PubMed ID: 8650971
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of cardiac amyloidosis made by ultrastructural examination of endomyocardial biopsy. A case report.
Arbustini E; Dander B; Buonanno C; Pennelli N; Zardini P; Thiene G
G Ital Cardiol; 1984 Jul; 14(7):512-6. PubMed ID: 6489663
[TBL] [Abstract][Full Text] [Related]
20. Iron storage disorders of the liver.
Grace ND; Powell LW
Gastroenterology; 1974 Dec; 67(6):1257-83. PubMed ID: 4609829
[No Abstract] [Full Text] [Related]
[Next] [New Search]
